What's New
Public Health Advisory: Suicidality in Children and Adolescents Being Treated with Antidepressant Medications - Manufacturers of all
antidepressant drugs asked to include in their labeling a boxed warning and expanded
warning statements that alert health care providers to an increased risk of
suicidality.
(Posted 10/15/2004)
Remicade (infliximab) - In controlled studies of all TNFα-blocking agents, including Remicade, more cases of lymphoma have been observed among patients receiving the agents than among control group patients.
(Posted 10/13/2004)
Rituxan (rituximab) - Reports of Hepatitis B reactivation with fulminant hepatitis, hepatic failure, and death in some patients.
(Posted 10/08/2004)
Levoxyl (levothyroxine sodium) - Reports of tablets stuck in throat, with choking, gagging and dysphagia, occurring predominately when not taken with water.
(Posted 10/04/2004)
Pulmonetic Systems LTV Series of Ventilators - Class I recall due to a malfunction when switching to the internal battery, causing failure of the
ventilator to breathe for the patient.
(Posted 9/30/2004)
Zometa (zoledronic acid) Injection - Reports of osteonecrosis of the jaw mainly in cancer patients, who have received bisphosphonates as a component of their therapy.
(Posted 9/30/2004)
Vioxx (rofecoxib) - Voluntary market withdrawal due to an increased risk for serious cardiovascular events, such as heart attacks and strokes, first observed after 18 months of continuous treatment with Vioxx compared with placebo.
(Posted 9/30/2004)
|